Annual Shareholders’ Meeting Results, Director Announcements and Director Independence
Fisher & Paykel Healthcare Corporation Limited (NZX:FPH, ASX:FPH) advises that all resolutions put to the company’s annual shareholders’ meeting held in Auckland today were passed. The seven resolutions were:
Resolution 1: To re-elect Michael Daniell as a Director.
Resolution 2: To re-elect Donal O’Dwyer as a Director.
Resolution 3: To elect Lewis Gradon as a Director.
Resolution 4: To elect Scott St John as a Director.
Resolution 5: To authorise the Directors to fix the fees and expenses of the Company’s auditor.
Resolution 6: To approve the issue of share rights to Lewis Gradon as set out in the Notice of Annual Shareholders’ Meeting 2016.
Resolution 7: To approve the issue of options to Lewis Gradon as set out in the Notice of Annual Shareholders’ Meeting 2016.
All resolutions were decided by poll. The details of the total number of votes cast in person or by proxy on the polls were as follows:
| Resolution | Votes For | % | Votes Against | Total Votes Cast | Abstain |
| Resolution 1 Re-election of Michael Daniell |
361,918,843 | 99.58 | 1,532,265 | 363,451,108 | 68,427 |
| Resolution 2: Re-election of Donal O’Dwyer | 354,672,109 | 98.19 | 6,521,473 | 361,193,582 | 3,325,609 |
| Resolution 3: Election of Lewis Gradon | 362,406,089 | 99.73 | 995,539 | 363,401,628 | 117,563 |
| Resolution 4: Election of Scott St John | 361,831,202 | 99.92 | 302,399 | 362,133,601 | 1,385,934 |
| Resolution 5: Authorise Directors to fix fees and expenses of auditor | 363,039,937 | 99.88 | 427,775 | 363,467,712 | 51,479 |
| Resolution 6: Issue of share rights to Lewis Gradon | 348,868,296 | 96.41 | 13,002,126 | 361,870,422 | 898,247 |
| Resolution 7: Issue of options to Lewis Gradon | 352,174,878 | 97.32 | 9,685,509 | 361,860,387 | 908,282 |
Independence of Directors
In accordance with NZX Listing Rule 3.3.3(a), the Board has determined that Tony Carter, Lindsay Gillanders, Geraldine McBride, Arthur Morris, Donal O’Dwyer and Scott St John are independent directors.
The factors that the Board considers in assessing the independence of directors are set out in the Board Charter, which can be viewed on the company’s website: www.fphcare.com/corporategovernance.
Contact: Tony Barclay, Company Secretary on +64 9 574 0119. For more information about the company visit our website www.fphcare.com.
About Fisher & Paykel Healthcare
Fisher & Paykel Fisher Healthcare is a leading designer, manufacturer and marketer of products and systems for use in acute and chronic respiratory care, surgery and the treatment of obstructive sleep apnea. The company’s products are sold in more than 120 countries worldwide. For more information about the company, visit our website www.fphcare.com.
Ends
Contact
|